Literature DB >> 19935810

Diabetes: RAS inhibition: probably not a one-size-fits-all approach.

Drazenka Pongrac Barlovic, Mark E Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19935810     DOI： 10.1038/nrneph.2009.189

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Authors:  N Chaturvedi; A K Sjolie; J M Stephenson; H Abrahamian; M Keipes; A Castellarin; Z Rogulja-Pepeonik; J H Fuller
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

2.  Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.

Authors:  M E Cooper; T J Allen; P A Macmillan; B E Clarke; G Jerums; A E Doyle
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

3.  Preventing microalbuminuria in type 2 diabetes.

Authors:  Piero Ruggenenti; Anna Fassi; Anelja Parvanova Ilieva; Simona Bruno; Ilian Petrov Iliev; Varusca Brusegan; Nadia Rubis; Giulia Gherardi; Federica Arnoldi; Maria Ganeva; Bogdan Ene-Iordache; Flavio Gaspari; Annalisa Perna; Antonio Bossi; Roberto Trevisan; Alessandro R Dodesini; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

4.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

5.  Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Authors:  Nish Chaturvedi; Massimo Porta; Ronald Klein; Trevor Orchard; John Fuller; Hans Henrik Parving; Rudy Bilous; Anne Katrin Sjølie
Journal:  Lancet       Date:  2008-09-25       Impact factor: 79.321

6.  Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Authors:  Michael Mauer; Bernard Zinman; Robert Gardiner; Samy Suissa; Alan Sinaiko; Trudy Strand; Keith Drummond; Sandra Donnelly; Paul Goodyer; Marie Claire Gubler; Ronald Klein
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

7.  Effect of telmisartan on renal outcomes: a randomized trial.

Authors:  Johannes F E Mann; Roland E Schmieder; Leanne Dyal; Matthew J McQueen; Helmut Schumacher; Janice Pogue; Xingyu Wang; Jeffrey L Probstfield; Alvaro Avezum; Ernesto Cardona-Munoz; Gilles R Dagenais; Rafael Diaz; George Fodor; Jean M Maillon; Lars Rydén; Cheuk M Yu; Koon K Teo; Salim Yusuf
Journal:  Ann Intern Med       Date:  2009-05-18       Impact factor: 25.391

8.  Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials.

Authors:  Rudy Bilous; Nish Chaturvedi; Anne Katrin Sjølie; John Fuller; Ronald Klein; Trevor Orchard; Massimo Porta; Hans-Henrik Parving
Journal:  Ann Intern Med       Date:  2009-05-18       Impact factor: 25.391

9.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.

Authors:  Jennifer L Wilkinson-Berka; Genevieve Tan; Kassie Jaworski; Jacqueline Harbig; Antonia G Miller
Journal:  Circ Res       Date:  2008-11-26       Impact factor: 17.367
  10 in total
  1 in total

Review 1.  Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.

Authors:  Munehiro Kitada; Shinji Kume; Ai Takeda-Watanabe; Keizo Kanasaki; Daisuke Koya
Journal:  Clin Sci (Lond)       Date:  2013-02       Impact factor: 6.124
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.